Search

Your search keyword '"Tsuboi, Masaya"' showing total 228 results
Start Over Author "Tsuboi, Masaya"
228 results on '"Tsuboi, Masaya"'

2. Whole exome and transcriptome analysis revealed the activation of ERK and Akt signaling pathway in canine histiocytic sarcoma

Author

Asada, Hajime, Tani, Akiyoshi, Sakuma, Hiroki, Hirabayashi, Miyuki, Matsumoto, Yuki, Watanabe, Kei, Tsuboi, Masaya, Yoshida, Shino, Harada, Kei, Uchikai, Takao, Goto-Koshino, Yuko, Chambers, James K., Ishihara, Genki, Kobayashi, Tetsuya, Irie, Mitsuhiro, Uchida, Kazuyuki, Ohno, Koichi, Bonkobara, Makoto, Tsujimoto, Hajime, and Tomiyasu, Hirotaka

Published
2023
Full Text
View/download PDF

3. Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade.

Author

Eto, Shotaro, Kato, Daiki, Saeki, Kohei, Iguchi, Takaaki, Shiyu, Qin, Kamoto, Satoshi, Yoshitake, Ryohei, Shinada, Masahiro, Ikeda, Namiko, Tsuboi, Masaya, Chambers, James, Uchida, Kazuyuki, Nishimura, Ryohei, and Nakagawa, Takayuki

Subjects
TRANSITIONAL cell carcinoma, TUMOR microenvironment, T cells, CELL populations, INDIVIDUALIZED medicine
Abstract

A comprehensive understanding of the tumour immune microenvironment (TIME) is essential for advancing precision medicine and identifying potential therapeutic targets. This study focused on canine urothelial carcinoma (cUC) recognised for its high sensitivity to cyclooxygenase (COX) inhibitors. Using immunohistochemical techniques, we quantified the infiltration of seven immune cell populations within cUC tumour tissue to identify clinicopathological features that characterise the TIME in cUC. Our results revealed several notable factors, including the significantly higher levels of CD3+ T cells and CD8+ T cells within tumour cell nests in cases treated with preoperative COX inhibitors compared to untreated cases. Based on the immunohistochemistry data, we further performed a comparative analysis using publicly available RNA‐seq data from untreated cUC tissues (n = 29) and normal bladder tissues (n = 4) to explore the link between COX–prostanoid pathways and the immune response to tumours. We observed increased expression of COX‐2, microsomal prostaglandin E2 synthase‐1 (mPGES‐1) and mPGES‐2 in cUC tissues. However, only mPGES‐2 showed a negative correlation with the cytotoxic T‐cell (CTL)–related genes CD8A and granzyme B (GZMB). In addition, a broader analysis of solid tumours using The Cancer Genome Atlas (TCGA) database revealed similar patterns in several human tumours, suggesting a common mechanism in dogs and humans. Our results suggest that the COX‐2/mPGES‐2 pathway may act as a cross‐species tumour‐intrinsic factor that weakens anti‐tumour immunity, and that COX inhibitors may convert TIME from a 'cold tumour' to a 'hot tumour' state by counteracting COX/mPGES‐2–mediated immunosuppression. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Comprehensive gene expression analysis in gallbladder mucosal epithelial cells of dogs with gallbladder mucocele.

Author

Nagao, Itsuma, Motegi, Tomoki, Goto‐Koshino, Yuko, Tsuboi, Masaya, Takahashi, Naohiro, Chambers, James K., Uchida, Kazuyuki, Baba, Kenji, Tomiyasu, Hirotaka, and Okuda, Masaru

Subjects
REVERSE transcriptase polymerase chain reaction, CHLORIDE channels, GENE expression profiling, GENE expression, TISSUE extracts
Abstract

Background: Gallbladder mucocele (GBM) is a common disease in the canine gallbladder. Although the pathogenesis of GBM remains unclear, we recently reported that the excessive accumulation of mucin in the gallbladder is not a result of overproduction by gallbladder epithelial cells (GBECs). Hypothesis/Objectives: Changes in the function of GBECs other than the production of mucin are associated with the pathogenesis of GBM. We performed an RNA sequencing (RNA‐seq) analysis to comprehensively search for abnormalities in gene expression profiles of GBECs in dogs with GBM. Animals: Fifteen dogs with GBM and 8 dogs euthanized for reasons other than gallbladder disease were included. Methods: The GBECs were isolated from gallbladder tissues to extract RNA. The RNA‐seq analysis was performed using the samples from 3 GBM cases and 3 dogs with normal gallbladders, and the gene expression profiles were compared between the 2 groups. Differences in mRNA expression levels of the extracted differentially expressed genes (DEGs) were validated by quantitative reverse transcription polymerase chain reaction (RT‐qPCR) using samples of 15 GBM cases and 8 dogs with normal gallbladders. Results: Comparison of gene expression profiles by RNA‐seq extracted 367 DEGs, including ANO1, a chloride channel associated with changes in mucin morphology, and HTR4, which regulates the function of chloride channels. The ANO1 and HTR4 genes were confirmed to be downregulated in the GBM group by RT‐qPCR. Conclusions and Clinical Importance: Our results suggest that GBM may be associated with decreased function of chloride channels expressed in GBECs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Bladder Reconstruction in Cats Using In-Body Tissue Architecture (iBTA)-Induced Biosheet.

Author

Fujita, Naoki, Sugiyama, Fumi, Tsuboi, Masaya, Nakamura, Hazel Kay, Nishimura, Ryohei, Nakayama, Yasuhide, and Fujita, Atsushi

Subjects
URINARY organs, CATS, PLASTIC surgery, URINARY incontinence, TISSUES, UROTHELIUM
Abstract

Urinary tract diseases are common in cats, and often require surgical reconstruction. Here, to explore the possibility of urinary tract reconstruction in cats using in-body tissue architecture (iBTA), biosheets fabricated using iBTA technology were implanted into the feline bladder and the regeneration process was histologically evaluated. The biosheets were prepared by embedding molds into the dorsal subcutaneous pouches of six cats for 2 months. A section of the bladder wall was removed, and the biosheets were sutured to the excision site. After 1 and 3 months of implantation, the biosheets were harvested and evaluated histologically. Implantable biosheets were formed with a success rate of 67%. There were no major complications following implantation, including tissue rejection, severe inflammation, or infection. Urinary incontinence was also not observed. Histological evaluation revealed the bladder lumen was almost entirely covered by urothelium after 1 month, with myofibroblast infiltration into the biosheets. After 3 months, the urothelium became multilayered, and mature myocytes and nerve fibers were observed at the implantation site. In conclusion, this study showed that tissue reconstruction using iBTA can be applied to cats, and that biosheets have the potential to be useful in both the structural and functional regeneration of the feline urinary tract. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Supplementary Figure 6 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 3 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure Legends from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 2 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

12. Data from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 2 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 5 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 7 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 9 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 8 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 4 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Materials and Methods from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, primary, Motegi, Tomoki, primary, Tsuboi, Masaya, primary, Ikeda, Namiko, primary, Aoki, Susumu, primary, Iguchi, Takaaki, primary, Li, Toshio, primary, Kodera, Yuka, primary, Ota, Ryosuke, primary, Hashimoto, Yuko, primary, Takahashi, Yosuke, primary, Chambers, James, primary, Uchida, Kazuyuki, primary, Kato, Yukinari, primary, Nishimura, Ryohei, primary, and Nakagawa, Takayuki, primary

Published
2023
Full Text
View/download PDF

23. Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease

Author

Uchida, Mona, primary, Matsumiya, Yuki, additional, Tsuboi, Masaya, additional, Uchida, Kazuyuki, additional, Nakagawa, Takayuki, additional, Fujii, Wataru, additional, Kobayashi, Tetsuya, additional, Tsujimoto, Hajime, additional, Ohmi, Aki, additional, Tomiyasu, Hirotaka, additional, Motegi, Tomoki, additional, Maeda, Shingo, additional, Momoi, Yasuyuki, additional, and Yonezawa, Tomohiro, additional

Published
2023
Full Text
View/download PDF

24. Cover Image

Author

Ohmi, Aki, primary, Tanaka, Miho, additional, Rinno, Jun, additional, Tsuboi, Masaya, additional, Chambers, James K., additional, Uchida, Kazuyuki, additional, Goto‐Koshino, Yuko, additional, Tomiyasu, Hirotaka, additional, Ohno, Koichi, additional, and Tsujimoto, Hajime, additional

Published
2023
Full Text
View/download PDF

25. Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma

Author

SHINADA, Masahiro, primary, KATO, Daiki, additional, TSUBOI, Masaya, additional, IKEDA, Namiko, additional, AOKI, Susumu, additional, IGUCHI, Takaaki, additional, LI, Toshio, additional, KODERA, Yuka, additional, OTA, Ryosuke, additional, KOSEKI, Shoma, additional, SHIBAHARA, Hayato, additional, TAKAHASHI, Yosuke, additional, HASHIMOTO, Yuko, additional, CHAMBERS, James K, additional, UCHIDA, Kazuyuki, additional, NOGUCHI, Shunsuke, additional, KATO, Yukinari, additional, NISHIMURA, Ryohei, additional, and NAKAGAWA, Takayuki, additional

Published
2023
Full Text
View/download PDF

28. Clinical characteristics and outcomes of Mott cell lymphoma in nine miniature dachshunds.

Author

Ohmi, Aki, Tanaka, Miho, Rinno, Jun, Tsuboi, Masaya, Chambers, James K., Uchida, Kazuyuki, Goto‐Koshino, Yuko, Tomiyasu, Hirotaka, Ohno, Koichi, and Tsujimoto, Hajime

Subjects
LYMPHOMAS, ALKYLATING agents, LARGE intestine, OVERALL survival, PROGRESSION-free survival
Abstract

Background: Lymphoma with Mott cell change, or Mott cell lymphoma (MCL), is an uncommon variant of canine lymphoma. Because of its rare occurrence, there has been no comprehensive study describing the disease so far. Miniature dachshunds, a popular breed in Japan, sometimes experience MCL. Objectives: To investigate the clinical characteristics and outcomes of MCL in miniature dachshunds. Methods: Medical records were retrospectively reviewed to identify miniature dachshunds diagnosed with MCL and other types of lymphoma. Data on clinical and laboratory findings, treatments and outcomes were collected. Survival times were compared between miniature dachshunds with MCL and other types of lymphoma. Results: Of the 87 miniature dachshunds diagnosed with lymphoma, 9 (10%) had cytological characteristics of MCL. All 9 miniature dachshunds with MCL were categorised as having alimentary lymphoma (small and/or large intestine, 6 dogs; mesenteric lymph node, 3 dogs). The median age was 3.1 years (range, 2.0–9.4 years). All nine dogs were treated with chemotherapeutic protocols used for large cell lymphoma or alkylating agents such as melphalan or chlorambucil. The overall response rate to initial chemotherapy was 78%, and the median progression‐free survival was 105 days. Overall survival in these nine dogs ranged from 6 to >1513 days (median, 240 days), which was significantly longer than in 29 miniature dachshunds with alimentary large cell lymphoma other than MCL (median, 57 days; p = 0.0491). Conclusions: MCL in miniature dachshunds can be recognised as a peculiar type of B‐cell lymphoma occurring in relatively young dogs as an alimentary form and has a longer survival compared with typical alimentary large cell lymphoma. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

29. Cover Image.

Author

Eto, Shotaro, Kato, Daiki, Saeki, Kohei, Iguchi, Takaaki, Shiyu, Qin, Kamoto, Satoshi, Yoshitake, Ryohei, Shinada, Masahiro, Ikeda, Namiko, Tsuboi, Masaya, Chambers, James, Uchida, Kazuyuki, Nishimura, Ryohei, and Nakagawa, Takayuki

Subjects
TRANSITIONAL cell carcinoma, TUMOR microenvironment
Abstract

The cover image is based on the article Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX‐Prostanoid Cascade by Shotaro Eto et al., https://doi.org/10.1111/vco.12999. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Rapid visualization of mammary gland tumor lesions of dogs using the enzyme-activated fluorogenic probe; γ-glutamyl hydroxymethyl rhodamine green

Author

HIROSE, Yui, primary, UCHIDA, Mona, additional, TSUBOI, Masaya, additional, NAKAGAWA, Takayuki, additional, YAGA, Leo, additional, MAEDA, Shingo, additional, MOMOI, Yasuyuki, additional, KURIKI, Yugo, additional, KAMIYA, Mako, additional, URANO, Yasuteru, additional, and YONEZAWA, Tomohiro, additional

Published
2022
Full Text
View/download PDF

32. Evaluation of the degree and distribution of lymphangiectasia in full-thickness canine small intestinal specimens diagnosed with lymphoplasmacytic enteritis and granulomatous lymphangitis

Author

NAGAHARA, Takuro, primary, OHNO, Koichi, additional, NAGAO, Itsuma, additional, NAKAGAWA, Taisuke, additional, GOTO-KOSHINO, Yuko, additional, TSUBOI, Masaya, additional, CHAMBERS, James K., additional, UCHIDA, Kazuyuki, additional, TOMIYASU, Hirotaka, additional, and TSUJIMOTO, Hajime, additional

Published
2022
Full Text
View/download PDF

37. Transmission of Helicobacter pylori between a human and two dogs: A case report

Author

Kubota‐Aizawa, Sanae, primary, Matsubara, Yasuo, additional, Kanemoto, Hideyuki, additional, Mimuro, Hitomi, additional, Uchida, Kazuyuki, additional, Chambers, James, additional, Tsuboi, Masaya, additional, Ohno, Koichi, additional, Fukushima, Kenjiro, additional, Kato, Naoya, additional, Yotsuyanagi, Hiroshi, additional, and Tsujimoto, Hajime, additional

Published
2021
Full Text
View/download PDF

39. Expression of podoplanin in various types of feline tumor tissues

Author

KAMOTO, Satoshi, primary, SHINADA, Masahiro, additional, KATO, Daiki, additional, TSUBOI, Masaya, additional, YOSHIMOTO, Sho, additional, YOSHITAKE, Ryohei, additional, ETO, Shotaro, additional, IKEDA, Namiko, additional, TAKAHASHI, Yosuke, additional, HASHIMOTO, Yuko, additional, CHAMBERS, James, additional, UCHIDA, Kazuyuki, additional, YAMADA, Shinji, additional, KANEKO, Mika K., additional, NISHIMURA, Ryohei, additional, KATO, Yukinari, additional, and NAKAGAWA, Takayuki, additional

Published
2021
Full Text
View/download PDF

40. Detection of indoleamine 2,3-dioxygenase 1–expressing cells in canine normal and tumor tissues

Author

IKEDA, Namiko, primary, KATO, Daiki, additional, TSUBOI, Masaya, additional, YOSHITAKE, Ryohei, additional, ETO, Shotaro, additional, YOSHIMOTO, Sho, additional, SHINADA, Masahiro, additional, KAMOTO, Satoshi, additional, HASHIMOTO, Yuko, additional, TAKAHASHI, Yousuke, additional, CHAMBERS, James, additional, UCHIDA, Kazuyuki, additional, NISHIMURA, Ryohei, additional, and NAKAGAWA, Takayuki, additional

Published
2021
Full Text
View/download PDF

41. Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma

Author

Kamoto, Satoshi, primary, Shinada, Masahiro, additional, Kato, Daiki, additional, Yoshimoto, Sho, additional, Ikeda, Namiko, additional, Tsuboi, Masaya, additional, Yoshitake, Ryohei, additional, Eto, Shotaro, additional, Hashimoto, Yuko, additional, Takahashi, Yosuke, additional, Chambers, James, additional, Uchida, Kazuyuki, additional, Kaneko, Mika K., additional, Fujita, Naoki, additional, Nishimura, Ryohei, additional, Kato, Yukinari, additional, and Nakagawa, Takayuki, additional

Published
2020
Full Text
View/download PDF

42. PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma

Author

Shinada, Masahiro, primary, Kato, Daiki, additional, Kamoto, Satoshi, additional, Yoshimoto, Sho, additional, Tsuboi, Masaya, additional, Yoshitake, Ryohei, additional, Eto, Shotaro, additional, Ikeda, Namiko, additional, Saeki, Kohei, additional, Hashimoto, Yuko, additional, Takahashi, Yosuke, additional, Chambers, James, additional, Uchida, Kazuyuki, additional, Kaneko, Mika K., additional, Fujita, Naoki, additional, Nishimura, Ryohei, additional, Kato, Yukinari, additional, and Nakagawa, Takayuki, additional

Published
2020
Full Text
View/download PDF

44. Supplemental Material, DS1_VET_10.1177_0300985818817024 - Assessment of Human Epidermal Growth Factor Receptor 2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder

Author

Tsuboi, Masaya, Kosei Sakai, Maeda, Shingo, Chambers, James K., Yonezawa, Tomohiro, Naoaki Matsuki, Uchida, Kazuyuki, and Nakayama, Hiroyuki

Subjects
70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, DS1_VET_10.1177_0300985818817024 for Assessment of Human Epidermal Growth Factor Receptor 2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder by Masaya Tsuboi, Kosei Sakai, Shingo Maeda, James K. Chambers, Tomohiro Yonezawa, Naoaki Matsuki, Kazuyuki Uchida, and Hiroyuki Nakayama in Veterinary Pathology

Published
2019
Full Text
View/download PDF

45. Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer

Author

YOSHIMOTO, Sho, primary, KATO, Daiki, additional, KAMOTO, Satoshi, additional, YAMAMOTO, Kie, additional, TSUBOI, Masaya, additional, SHINADA, Masahiro, additional, IKEDA, Namiko, additional, TANAKA, Yuiko, additional, YOSHITAKE, Ryohei, additional, ETO, Shotaro, additional, SAEKI, Kohei, additional, CHAMBERS, James, additional, HASHIMOTO, Yuko, additional, UCHIDA, Kazuyuki, additional, NISHIMURA, Ryohei, additional, and NAKAGAWA, Takayuki, additional

Published
2020
Full Text
View/download PDF

47. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells

Author

Eto, Shotaro, primary, Saeki, Kohei, additional, Yoshitake, Ryohei, additional, Yoshimoto, Sho, additional, Shinada, Masahiro, additional, Ikeda, Namiko, additional, Kamoto, Satoshi, additional, Tanaka, Yuiko, additional, Kato, Daiki, additional, Maeda, Shingo, additional, Tsuboi, Masaya, additional, Chambers, James, additional, Uchida, Kazuyuki, additional, Nishimura, Ryohei, additional, and Nakagawa, Takayuki, additional

Published
2019
Full Text
View/download PDF

50. Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma

Author

YOSHIMOTO, Sho, primary, KATO, Daiki, additional, KAMOTO, Satoshi, additional, YAMAMOTO, Kie, additional, TSUBOI, Masaya, additional, SHINADA, Masahiro, additional, IKEDA, Namiko, additional, TANAKA, Yuiko, additional, YOSHITAKE, Ryohei, additional, ETO, Shotaro, additional, SAEKI, Kohei, additional, CHAMBERS, James Kenn, additional, KINOSHITA, Ryohei, additional, UCHIDA, Kazuyuki, additional, NISHIMURA, Ryohei, additional, and NAKAGAWA, Takayuki, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results